Shelley W - Search Results

1

Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma.

Wilson K, Shelley W, Belch A, Brandes L, Bergsagel D, Klimo P, White D, Willan A. Wilson K, et al. Among authors: shelley w. Cancer Treat Rep. 1987 Oct;71(10):981-2. Cancer Treat Rep. 1987. PMID: 3652060

2

A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients.

Belch A, Shelley W, Bergsagel D, Wilson K, Klimo P, White D, Willan A. Belch A, et al. Among authors: shelley w. Br J Cancer. 1988 Jan;57(1):94-9. doi: 10.1038/bjc.1988.17. Br J Cancer. 1988. PMID: 3279997 Free PMC article. Clinical Trial.

3

Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.

Pater JL, Carmichael JA, Krepart GV, Fraser RC, Roy M, Kirk ME, Levitt M, Brown LB, Wilson KS, Shelley WE, et al. Pater JL, et al. Among authors: shelley we. Cancer Treat Rep. 1987 Mar;71(3):277-81. Cancer Treat Rep. 1987. PMID: 3102056 Clinical Trial.

4

Adriamycin and cisplatin in the treatment of stage III and IV epithelial ovarian carcinoma.

Shelley WE, Carmichael JC, Brown LB, Fraser RC, Kirk ME, Krepart GV, Levitt M, Roy M, Willan AR, Wilson KS. Shelley WE, et al. Gynecol Oncol. 1988 Feb;29(2):208-21. doi: 10.1016/0090-8258(88)90215-6. Gynecol Oncol. 1988. PMID: 3338672

5

The use of VP-16 plus cisplatin during induction chemotherapy for small-cell lung cancer.

Evans WK, Feld R, Murray N, Pater J, Shelley W, Willan A, Osoba D, Levitt M, Coy P, Hodson I, et al. Evans WK, et al. Among authors: shelley w. Semin Oncol. 1986 Sep;13(3 Suppl 3):10-6. Semin Oncol. 1986. PMID: 3020692 Review.

6

A predictive index of cure versus no cure in advanced ovarian carcinoma patients--replacement of second-look laparotomy as a diagnostic test.

Carmichael JA, Shelley WE, Brown LB, Fraser RC, Kirk ME, Krepart GV, Levitt M, Roy M, Willan AR, Wilson KS. Carmichael JA, et al. Among authors: shelley we. Gynecol Oncol. 1987 Jul;27(3):269-81. doi: 10.1016/0090-8258(87)90246-0. Gynecol Oncol. 1987. PMID: 3623227

7

High-dose-intensity regimen of weekly doxorubicin and cisplatin in the treatment of patients with stage III and IV epithelial ovarian carcinoma.

O'Connell G, Shelley W, Carmichael J, Fraser R, Kirk ME, Krepart G, Levin L, Swenerton K. O'Connell G, et al. Among authors: shelley w. Cancer Treat Rep. 1987 May;71(5):455-8. Cancer Treat Rep. 1987. PMID: 3567969

8

Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.

Quirt IC, Shelley WE, Pater JL, Bodurtha AJ, McCulloch PB, McPherson TA, Paterson AH, Prentice R, Silver HK, Willan AR, et al. Quirt IC, et al. Among authors: shelley we. J Clin Oncol. 1991 May;9(5):729-35. doi: 10.1200/JCO.1991.9.5.729. J Clin Oncol. 1991. PMID: 2016615 Clinical Trial.

9

Toxicity of abdominopelvic radiation in advanced ovarian carcinoma patients after cisplatin/cyclophosphamide therapy and second-look laparotomy.

Shelley WE, Starreveld AA, Carmichael JA, O'Connell G, Roy M, Swenerton K. Shelley WE, et al. Obstet Gynecol. 1988 Mar;71(3 Pt 1):327-32. Obstet Gynecol. 1988. PMID: 3347416

10

Lomustine, vincristine, and procarbazine in the treatment of metastatic malignant melanoma.

Shelley W, Quirt I, Bodurtha A, Iscoe N, Russell J, Paterson A, Young V. Shelley W, et al. Cancer Treat Rep. 1985 Sep;69(9):941-4. Cancer Treat Rep. 1985. PMID: 2992784

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

602 results

Search Page

Filters